Science Explorer Back to mapMap
Discussion
Researcher · ABL Bio (South Korea) · South Korea

Byungje Sung

Byungje Sung publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and HER2/EGFR in Cancer Research.

ORCID 0009-0001-1806-2125 OpenAlex
World rank
#2,064,231
of 7,710,434 ranked researchers
Rank in South Korea
#26,168
of 162,609
Works
16
Citations
1.1k
Citations per work
67.9
h-index
7
i10-index 7Top 78% in Oncology
Byungje Sung

What does Byungje Sung research?

Byungje Sung's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (9%).

Health Sciences: 9 works · 58.8% of their workMedicine: 9 works · 58.8% of their workOncology: 5 works · 28.3% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 19.6% of their workNeurology: 2 works · 10.9% of their workLife Sciences: 5 works · 28.3% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 19.6% of their workMolecular Biology: 3 works · 17.4% of their workCancer Research: 0 works · 2.2% of their workImmunology and Microbiology: 1 works · 8.7% of their workImmunology: 1 works · 8.7% of their workEverything else: 2 works · 12.9% of their workTHEIR WORKByungje Sung16works
Life Sciences28%Health Sciences59%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine958.8%
    1. Biochemistry, Genetics and Molecular Biology319.6%
    2. Immunology and Microbiology18.7%
  3. Everything else212.9%
  1. 1Oncology28% of their works
  2. 2Radiology, Nuclear Medicine and Imaging20% of their works
  3. 3Molecular Biology17% of their works
  4. 4Neurology11% of their works
  5. 5Immunology9% of their works
  6. 6Cancer Research2% of their works

Research topics

Which keywords describe Byungje Sung's research?

The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Breast Cancer, HER2 and Parkinson's Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Fc Receptors81 topic
  2. Therapeutic Antibodies81 topic
  3. Cancer Immunotherapy72 topics
  4. CAR T Cells51 topic
  5. Chimeric Antigen Receptor51 topic
  6. Breast Cancer41 topic
  7. HER241 topic
  8. Parkinson's Disease42 topics
  9. Apoptosis31 topic
  10. Cell Death31 topic
  11. Deep Brain Stimulation21 topic
  12. Dendritic Cells21 topic
  13. Immune Checkpoint Blockade21 topic
  14. Immunity21 topic
  15. Neurodegeneration21 topic
  16. PD-1 and PD-L121 topic
  17. Subthalamic Nucleus21 topic
  18. a-Synuclein21 topic

Where does Byungje Sung work?

Byungje Sung's main affiliation in the publication record is ABL Bio (South Korea), South Korea.

How many publications and citations does Byungje Sung have?

OpenAlex counts 16 works and 1,086 citations for Byungje Sung, an h-index of 7, ranking #2,064,231 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Byungje Sung. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.